Problem-solving intervention aids young adults with cancer

Young adults with cancer who participated in a one-on-one problem-solving intervention experienced improvements in anxiety, depression and quality of life, according to a study published in JAMA Network Open.
Across six sessions, Bright IDEAS-YA helps patients learn to identify problems, define and evaluate their options, act, and see if their solution worked.
For patients who took part in the intervention, depression and anxiety scores on the Patient-Reported Outcomes Measurement Information System Short Forms were 3.23 and 2.43 points lower than those in the comparison group 6 months later,

Therapies to lower BP, lipids close gap in obesity-related CVD

With wider use of antihypertensive and lipid-lowering therapies, people with overweight/obesity may reach similar blood pressure and cholesterol levels compared with people with normal BMI, researchers reported.
Lower use of these medications among people younger than 40 years may contribute to the wider gap in BP and cholesterol among people with overweight/obesity compared with those with normal BMI in this age range, according to data published in The Lancet.
“Our study suggests that, in high-income countries, taking medication to lower blood pressure and cholesterol has helped middle-age

Closed-loop system with insulin lispro and pramlintide beneficial

NEW ORLEANS — Adults with type 1 diabetes had a similar time in range using automated insulin delivery with ultrarapid-acting insulin lispro-aabc and pramlintide compared with insulin lispro-aabc alone, according to a speaker.
In findings from a randomized crossover trial presented at the American Diabetes Association Scientific Sessions, use of a fully closed-loop automated insulin delivery system that delivered both insulin lispro-aabc (Lyumjev, Eli Lilly) and pramlintide (Symlin, AstraZeneca) conferred similar glycemic outcomes and resulted in a lower daily insulin dose compared with

Suboptimal dialysis starts may impact transplant referral odds

Suboptimal dialysis starts may be associated with lower odds for transplant referral, evaluation and wait-listings, according to study data published in Nature Communications Medicine.
Several clinical guidelines define an optimal dialysis start as any planned start of peritoneal dialysis or hemodialysis with an arteriovenous fistula or graft or preemptive kidney transplant, according to Megan Urbanski, PhD, MSW, assistant professor in the division of transplantation, department of surgery at Emory University School of Medicine, and colleagues. The researchers aimed to evaluate whether

Blood-based lung cancer screening test raises screening rate

ORLANDO — More patients in primary care practices with vs. without access to a blood-based lung cancer screening test received screening, according to findings presented at the American Thoracic Society International Conference.
“It looks like access to this particular blood test does, in fact, increase lung cancer screening rates and increases them in a way that would be clinically meaningful,” James M. Davis, MD, medical director for Duke Center for Smoking Cessation, director of the Duke smoking Cessation program and co-director of the Duke-UNC tobacco treatment specialist credentialing

Asthma inhaler use lower in Black, Hispanic, Asian adults

Lower percentages of Black, Hispanic and Asian adults with asthma used inhaled corticosteroid, long-acting beta-agonist and long-acting muscarinic antagonist inhalers vs. white adults in 2014 to 2023, according to results published in JAMA.
This disparity is likely due to socioeconomic characteristics and health care access factors, according to researchers.
“In our study, we found racial and ethnic differences in inhaled corticosteroid (ICS) use that was mostly (but not completely) attenuated in our fully adjusted model,” Utibe R. Essien, MD, MPH, assistant professor of medicine at the David

Cannabis use, products vary among patients with rheumatic disease

An online survey of 1,436 patients with rheumatic disease revealed “significant variability” in cannabis products used, efficacy and side effects, which were driven by several patient-specific factors, according to a study.
“Our findings may provide guidance for clinicians and patients in the choice of cannabis products they use, given the wide range of marketed products in Canada with the advent of recreational cannabis legalization,” Susan Zhang, PharmD, from the University of Alberta, and colleagues wrote in Arthritis Care & Research.
From March 2022 to November